Senior Director, U.S. CAR T Marketing Liso-Cel at Bristol-Myers Squibb
Seattle, Washington
Associate Director, XTANDI Marketing Oncology & Urology @ Pfizer From September 2016 to January 2017 (5 months) San Francisco Bay AreaAssociate Director, XTANDI Marketing Oncology & Urology @ Medivation From January 2016 to September 2016 (9 months) San Francisco Bay AreaProduct Marketing Manager @ Amgen Enbrel promotions marketing From February 2011 to May 2013 (2 years 4...
Associate Director, XTANDI Marketing Oncology & Urology @ Pfizer From September 2016 to January 2017 (5 months) San Francisco Bay AreaAssociate Director, XTANDI Marketing Oncology & Urology @ Medivation From January 2016 to September 2016 (9 months) San Francisco Bay AreaProduct Marketing Manager @ Amgen Enbrel promotions marketing From February 2011 to May 2013 (2 years 4 months) Pharmaceutical Sales @ Merck Fosamax, Singulair From 2004 to 2007 (3 years) Senior Director, U.S. CAR T Marketing Liso-Cel @ Bristol-Myers Squibb Seattle, WashingtonSenior Director, U.S. CAR T Marketing Liso-Cel @ Celgene Brand Leader From November 2018 to November 2019 (1 year 1 month) Greater Seattle AreaSr. Manager; Product Strategy - Hematology @ Amgen Blinatumomab U.S. Launch Team.Sr. Product Manager – Promotions Marketing & Strategy, Launch Brand Team – BLINCYTO® for the treatment of Acute Refractory/Relapsed Lymphoblastic Leukemia, Philadelphia B negative - an orphan disease classification and Breakthrough Therapy designation by the FDA. Utilizing novel BiTE technology, FDA approved BLA in just 75 days based on Phase II data.Summary - Blinatumomab U.S. launch team. LCM strategy: Developing Pediatric indication strategy, targeting, messages. Mandatory OPDP promotional tools pre-clearance – responsible for Wave 2 OPDP submission.• Marketing – Lead on Core Visual Aid, Blincyto.com, and all Multi-Channel strategy and Journal advertisements including web banners and print journal development and the OPDP submission for Wave 2 pre-clearance.o Market Research – multi-city qualitative research on Wave 2 CVA and messageso Onyx integration Teammate – Blincyto is first molecule to move from Amgen to Onyx. Advisory member on Integration team to ensure knowledge transfer is successful.• Strategy Planning – Lead on Pediatric Indication strategy, From November 2014 to December 2015 (1 year 2 months) San Francisco Bay AreaSr. Product Marketing Manager @ Amgen Evolocumab (AMG-145) U.S. launch team. • Market Development – U.S. strategy and Disease Education targeting U.S. HCPs on a new class of mAbs that targets the PCSK9. From May 2013 to November 2014 (1 year 7 months) Thousand OaksSr. Biopharmaceutical Sales Rep @ Amgen Nephrology Portfolio - Key Accounts including Large & Small Dialysis Organizations, System Hospitals, Injection Clinics and Nephrology medical clinics. From February 2007 to February 2011 (4 years 1 month) San Francisco Bay AreaMarketing Director, U.S. CAR T Marketing Liso-Cel @ Juno Therapeutics, Inc. HCP Promotions Marketing Director From January 2017 to November 2018 (1 year 11 months) Seattle
Pfizer
Associate Director, XTANDI Marketing Oncology & Urology
September 2016 to January 2017
San Francisco Bay Area
Medivation
Associate Director, XTANDI Marketing Oncology & Urology
January 2016 to September 2016
San Francisco Bay Area
Amgen
Product Marketing Manager
February 2011 to May 2013
Merck
Pharmaceutical Sales
2004 to 2007
Bristol-Myers Squibb
Senior Director, U.S. CAR T Marketing Liso-Cel
Seattle, Washington
Celgene
Senior Director, U.S. CAR T Marketing Liso-Cel
November 2018 to November 2019
Greater Seattle Area
Amgen
Sr. Manager; Product Strategy - Hematology
November 2014 to December 2015
San Francisco Bay Area
Amgen
Sr. Product Marketing Manager
May 2013 to November 2014
Thousand Oaks
Amgen
Sr. Biopharmaceutical Sales Rep
February 2007 to February 2011
San Francisco Bay Area
Juno Therapeutics, Inc.
Marketing Director, U.S. CAR T Marketing Liso-Cel
January 2017 to November 2018
Seattle
What company does Daniel Malakoti work for?
Daniel Malakoti works for Pfizer
What is Daniel Malakoti's role at Pfizer?
Daniel Malakoti is Associate Director, XTANDI Marketing Oncology & Urology
What industry does Daniel Malakoti work in?
Daniel Malakoti works in the Biotechnology industry.
Who are Daniel Malakoti's colleagues?
Daniel Malakoti's colleagues are Russell Towell, Cristiane Oliveira, Eddy Paulino @Eddy_Paulino, Anette Kjer Overgaard, Luis Gerardo Encarnacion-Gomez, Kate Cox, Hossain Monshizadegan, Theresa Duffy, Bethany Baumgart, and Chenyang Shi
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies
Daniel Malakoti's Social Media Links
/school/us... /company/b...